The Infection Control Market Is Growing With High Prevalence of Infectious Diseases 2028 | Halyard Health, Metrex Research, Reckitt Benckiser, Pal International

The Infection Control Market Is Growing With High Prevalence of Infectious Diseases

The global infection control market is estimated To exhibit a CAGR of 13.3% over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Infections are mainly caused by microorganisms such as bacteria, virus, and fungi or parasites. Infections can be of different types such as sexually transmitted infections, hospital acquired infections (HAIs), eye infections, skin infections, ear infections, lung & respiratory infections, and stomach and intestinal infections, among others.

𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/4126

Infection control prevents or stops the spread of infections in healthcare settings. According to the World Health Organization (WHO), infection prevention & control is a practical, evidence-based approach used to prevent health workers and patients from being harmed by avoidable infections. Infection control precautions are a set of standard recommendations used to reduce the risk of transmission of infectious agents from body fluids or environmental surfaces that contain infectious agents.

Competitive Landscape:

Major players operating in the global infection control market are Kimberly-Clark Corporation, Sterigenics International Inc., Matachana, Belimed AG, Sotera Health, Ecolab, Cantel Medical, Getinge AB, STERIS Corporation, Ahlstrom Corporation, Cisa S.p.A, Honeywell International Inc., MMM Group, 3M Healthcare company, Nordion Inc., Reckitt Benckiser, Synergy Health plc, Pal International, Metrex Research, Halyard Health, Sakura Global Holding Company Ltd., and Advanced Sterilization Products (Johnson & Johnson Limited), among others.

Key Market Drivers:

Increasing number of surgical procedures and high incidence of hospital-acquired infections is expected to augment the growth of the infection control market during the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), hospital-acquired infections (HAIs) account for an estimated 1.7 million infections and 99,000 associated deaths each year, in American hospitals alone.

Moreover, increasing incidence of chronic diseases, growing geriatric population, and growing awareness among people about personal hygiene due to the COVID-19 outbreak is expected to augment the growth of the infection control market. For instance, according to the WHO, older people, and those with underlying medical problems such as cardiovascular disease, diabetes, and cancer are at higher risk of developing serious illness from COVID-19.

𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/4126

COVID-19 Impact Analysis:

According to the WHO, around 30 new diseases emerged in the last 20 years, and infectious diseases kill 17 million people every year. The World Health Organization (WHO) on March 11, 2020, declared the novel coronavirus (COVID-19) outbreak a global pandemic. COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Worldwide, as of 6:32pm CET, 14 February 2022, there have been 410,565,868 confirmed cases of COVID-19, with 5,810,880 deaths. Thus, there is an increasing demand for infection control. This, in turn, is expected to aid in the growth of the infection control market.

Key Takeaways:

• The infection control market is expected to exhibit a CAGR of 13.3% during the forecast period due to the introduction of novel products to prevent or stop the spread of infections. For instance, in September 2021, Sodexo launched an improved, evidence-based infection prevention approach called Protecta for hospitals to fight against HAIs. This new approach will promote and support the adoption of best practices, while meeting the new National Standards of Healthcare Cleanliness.
• Among regions, North America, Europe, and Asia Pacific are expected to witness robust growth in the infection control market due to the increasing prevalence of chronic diseases, high incidence of hospital-acquired infections, outbreak of COVID-19, growing geriatric population, government initiatives, and introduction of novel products in these regions. For instance, in October 2020, to fight against infectious disease, CDC launched a $ 180 million program, called Project Firstline, to help stop the spread of pathogens in healthcare settings and protect frontline healthcare workers.